The improved form perindopril in treatment of arterial hypertension in various clinical situations (PREMIA)

The treatment of ACE inhibitors reduce risk of cardiovascular morbidity and mortality. The patients with grade 1-2 hypertension (n=2060) and at least one additional risk factors, subclinical organ damage, established CV or renal disease, diabetes mellitus or metabolic syndrome are recruited in this...

Full description

Saved in:
Bibliographic Details
Published inSistemnye gipertenzii (Online) Vol. 6; no. 4; pp. 50 - 53
Main Authors Viktoriya Borisovna Mychka, Yu V Zhernakova, Irina Evgen'evna Chazova
Format Journal Article
LanguageRussian
Published IP Morozov P.V 15.12.2009
Subjects
ace inhibitors
arterial hypertension
perindopril
Online AccessGet full text

Cover

More Information
Summary:The treatment of ACE inhibitors reduce risk of cardiovascular morbidity and mortality. The patients with grade 1-2 hypertension (n=2060) and at least one additional risk factors, subclinical organ damage, established CV or renal disease, diabetes mellitus or metabolic syndrome are recruited in this clinical study. The article presented of study design.
ISSN:2075-082X
2542-2189
DOI:10.26442/SG33090